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Abstract.  Muscle development in vivo involves a 
complex sequence of cell-cell interactions  in which 
secondary myotubes first form in association with pri- 
mary myotubes and  subsequently separate from them. 
We show here that during this process N-cadherin and 
the different structural  forms of NCAM are regulated 
in a pattern that involves both temporal changes in ex- 
pression and localization to particular regions of the 
muscle cell surface.  In particular,  levels of N-cadherin 
on maturing  myotubes are decreased, and the form of 
NCAM synthesized by the muscle changes from a 
transmembrane  non-polysialylated to a lipid-linked 
polysialylated membrane protein.  Moreover, while 
NCAM was distributed on all myotube surfaces, the 
polysialylated form of NCAM was restricted to 
regions of the myotube surface that had recently sepa- 
rated from neighboring  cells. We previously found that 
blockade of nerve-induced activity by d-Tubocurarine 
perturbed muscle cell interactions,  resulting  in a fail- 
ure of myotubes to separate.  We now show that this 
activity blockade also alters adhesion molecule expres- 
sion.  First,  N-cadherin  was no longer down-regulated 
in maturing  myotubes, and its persistence on the sur- 
faces of mature myotubes may partly explain their fail- 
ure to separate.  Secondly, the developmental switch 
from transmembrane  to lipid-linked NCAM did not 
occur, and polysialylated NCAM was no longer 
formed. As the unusual physical properties of PSA 
have been proposed to impede cell-cell interactions, 
this alteration would also be expected to compromise 
cell separation.  Together,  these results suggest that the 
regulated expression of both N-cadherin and NCAM 
isoforms including their polysialylation, is an essential 
mechanism for the normal separation of secondary myo- 
tubes from primary myotubes. 
T 
hE  formation of skeletal  muscles occurs in a series 
of highly orchestrated cellular  interactions  involving 
several populations  of cells.  After migrating  into the 
limb bud, myogenic cells condense into dorsal and ventral 
muscle masses which then cleave to form individual muscles 
(Christ  et al.,  1977; Chevallier  et al.,  1977).  Within  the 
masses, muscle precursor cells divide, differentiate, and fuse 
to form multinucleated  myotubes.  Although  the myogenic 
precursors that give rise to all of the adult myofibers are pres- 
ent in the limb bud at the onset of muscle formation,  they 
differentiate  asynchronously giving rise to two populations 
of myotubes that are classified as primary or secondary myo- 
tubes, according to the time at which they form (Ashmore 
et al.,  1972; Kelly and Zacks, 1969; Ross et al.,  1987). A 
third population of myogenic cells known as satellite  cells 
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persists in adult muscle (Albrook et al., 1971; Ontell,  1977; 
Shultz,  1974). 
Anatomical studies have provided detailed descriptions  of 
cellular  interactions  during  in  vivo muscle  formation  of 
mammalian  and avian species (Kelly and Zacks,  1969; Ash- 
more et al.,  1972;  Ontell,  1977; Ontell,  1977; Ontell  and 
Kozeka, 1984; Ross et al., 1987; Duxson et al., 1989). From 
these studies, we know that until late in development of both 
mammalian  and avian species (until  embryonic day 13 [St 
39]  for chick, and during  postnatal development  for rats), 
myotubes are organized  into clusters that  also contain the 
precursors  for  subsequently  formed  myotubes.  The  cells 
within clusters share close membrane appositions,  and are 
enclosed within a common basal lamina which surrounds the 
cluster,  but which does not penetrate between individual 
cells of the cluster.  The surfaces of myotubes within these 
clusters serve as substrates on which myoblasts fuse to form 
other myotubes, and thus,  all secondary myotubes form on 
the surfaces of previously formed myotubes.  As myotubes 
mature,  they  separate  from  the  cluster  and  become en- 
sheathed  in their own basal lamina.  Eventually,  the entire 
©  The Rockefeller University Press, 0021-9525/93/12/1867/22 $2.00 
The Journal of Cell Biology, Volume 123, Number 6, Part 2, December 1993 1867-1888  1867 muscle becomes populated by individual myofibers which 
have undifferentiated satellite cells adhering to them. 
Clearly cell-cell  interactions play an important role in 
these aspects of muscle development. Accordingly, a number 
of  cell  adhesion  molecules  (CAMs) ~ that  may  mediate 
cell-cell interactions during myogenesis are expressed in de- 
veloping muscle. These include NCAM (Covault and Sanes, 
1986; Covault et al., 1986; Tosney et al., 1986), N-cadherin 
(Hahn and Covault,  1992),  M-cadherin (Donalies et al., 
1991), and integrin receptors (Bixby et al.,  1987; Rosen et 
al.,  1992;  Bozyczko et al.,  1989;  Menko and Boetinger, 
1987) and the expression of some of these CAMs has been 
related to particular phases of myogenesis (Tosney et al., 
1986;  Covault and Sanes,  1986;  Covault et al.,  1986).  For 
example, a switch from the expression of the transmembrane 
isoform of NCAM to the low molecular weight, lipid-linked 
isoform occurs during secondary myogenesis (Covault et al., 
1986).  However, that study did not determine if the expres- 
sion of the lipid-linked form was restricted to  secondary 
myotubes and myoblasts. In fact, few studies have described 
differential localization of CAMs to particular muscle cell 
surfaces. Soler and Knudsen (1991) found that NCAM and 
N-cadherin were co-localized on myoblasts in culture, but 
did not describe their distribution on myotubes. Another 
study observed that, while both NCAM and N-cadherin were 
found on myoblasts, only NCAM persisted on myotubes after 
fusion (Mege et al., 1992). Recently, Rosen and co-workers 
(Rosen et al.,  1992) found that the integrin VLA-4 was ex- 
pressed on both primary and secondary myotubes, while 
VCAM-1, which binds to VLA-4, was restricted to second- 
ary myoblasts and to the surfaces of myotubes apposed to 
these myoblasts. They also found that antibodies against ei- 
ther of these molecules were capable of blocking myotube 
formation in vitro. 
Neuromuscular transmission is another form of cell-cell 
interaction that has been shown to influence myotube devel- 
opment.  In  a  previous  study (Fredette  and  Landmesser, 
1991b), we observed that blocking neuromuscular transmis- 
sion with d-tubocurarine during primary and secondary myo- 
genesis resulted in striking perturbations in myotube orga- 
nization. Although both primary and secondary myotubes 
formed, the clusters containing these cells were greatly en- 
larged when compared to those in control muscles. While 
some hypertrophy of the myotubes occurred, the increased 
cluster size was mostly due to an increase in the number of 
myotubes in each cluster.  These observations suggest that 
following activity blockade there is an increased adhesive- 
ness among muscle cells, resulting in a failure of myotubes 
to separate from their clusters. NCAM and N-cadherin have 
been shown to participate in myoblast aggregation, which is 
a  prerequisite  for  fusion  (Knudsen  and  Horowitz  1977; 
Knudsen et al., 1990a,b). Furthermore, since the expression 
of both NCAM and N-cadherin is down regulated in chicken 
muscle before hatching, but is  rapidly up-regulated after 
denervation  (Covault and  Sanes,  1985, 1986;  Hahn  and 
Covault, 1992), these CAMs are good candidates to partici- 
pate  in  the  perturbations  we  observed  following activity 
blockade. 
1. Abbreviations  used in this paper: CAM, call adhesion molecule; MSD, 
muscle-specific domain; PI-PLC, phosphatidylinositol-specific phospholi- 
pase C; PSA, polysialic acid. 
Most investigations of the mechanisms underlying muscle 
formation have focused on the initial events such as cell-cell 
recognition and membrane fusion, and have been performed 
in vitro with precursors of secondary myotubes or with satel- 
lite cells (Knudsen et al.,  1989, 1990a,b;  Entwistle et al., 
1988a,b; Menko and Boetinger, 1987; Mege et al.,  1992). 
While these in vitro studies provide important insights into 
these events,  they do not address the cell-cell interactions 
occurring among the heterogeneous populations of ceils that 
exist in vivo.  Such interactions include not only the fusion 
of myoblasts on myotube surface substrates, but also the sub- 
sequent separation of myotubes from clusters. 
We present here an in-depth study of how N-cadherin and 
the different structural forms of NCAM are expressed and 
distributed on muscle surfaces as they form and separate 
from clusters during primary and secondary myogenesis. A 
complex expression pattern was found for these two CAMs, 
that involved both temporal changes and localization to par- 
ticular cell-surface compartments during the two phases of 
myogenesis. Furthermore, we provide evidence that selec- 
tive glycosylation of muscle NCAM isoforms may be an im- 
portant new parameter in myotube development. That is, 
myotubes display the polysialylated and nonpolysialylated 
forms on different regions of  the cell surface in a pattern that, 
in view of the ability of polysialic acid (PSA) to regulate cell 
interactions, may be related to separation of myotubes from 
clusters. Consistent with this hypothesis we found that fol- 
lowing activity blockade, the distribution of N-cadherin was 
altered and that expression of the polysialylated form of 
NCAM was virtually abolished. We suggest that these mo- 
lecular changes may underlie the perturbations in muscle or- 
ganization produced by activity blockade and therefore, that 
a decrease in N-cadherin expression at appositions between 
maturing myotubes, as well as an increase in polysialylated 
NCAM on muscle cell surfaces are necessary for myotube 
separation from clusters. 
Materials and Methods 
D-Tubocurarine Treatment  of  Embryos 
Embryos (obtained from the University of Connecticut Poultry Depart- 
ment, Storrs, CT) were raised from fertilized white leghorn chicken eggs 
in a forced-draft incubator at 38°C. Developmental stages of the embryos 
were determined according to the criteria of Hamburger and Hamilton 
(1951). At St 27 (day 5 in ovo), square openings were made in the egg shells, 
and coverslips were sealed over the openings with paraffin to  serve as 
replaceable windows for drug treatments. Beginning at St 27, one group of 
embryos received daily applications of d-tubocurarine (dTC) (Sigma lm- 
munochemicals, St. Louis) (2 rag in sterile 0.9% NaCI) onto the chorioal- 
lantoic membrane, a procedure previously shown to be sufficient for block- 
ing  nerve-evoked muscle contractions (Pittman and  Oppenheim,  1979; 
Dahm and Landmesser, 1988). A second group, consisting of untreated em- 
bryos and embryos receiving saline instead of d-tubocurarine, served as 
controls. 
Immunofluorescence 
Three antibodies to NCAM were used: 5E, a monoclonal IgG antibody that 
recognizes all molecular weight forms of NCAM  (Frelinger and Rutis- 
hauser, 1986);  5A5, a monoclonal IgM which recognizes the polysialylated 
form of NCAM (Dodd et al.,  1988;  Acheson et al., 1991),  and cx735D4, 
a monoclonal IgG also against polysialic acid (Frosch et al.,  1985;  Finne 
et al., 1987).  Two antibodies against N-cadherin were used and gave identi- 
cal results: a mouse monoclonal antibody GC-4 (Volk et al., 1990) obtained 
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provided by M.  Takeichi  (Kyoto University, Japan). 
Hindlimbs of the dTC-treated embryos were embedded and frozen along 
with stage-matched control hindlimbs in OCT (Miles Scientific, Elkhart, 
IN) either directly after dissection in Tyrode buffer, or after being fixed for 
30 rain in 3.7% formaldehyde in PBS (pH 8.0). Cryosections, 10-#m thick, 
were cut transverse to the hindlimb throughout the thigh, and dried onto 
gelatin-coated slides. The sections from the freshly frozen hindlimbs were 
fixed for 15 rain before immunostaining. All sections were then processed 
for immunocytochemistry by first incubating for 2 h at room temperature 
with one of the following primary antibodies diluted in PBS and 2 % bovine 
serum albumin: 5E;  5A5; c~735IM; GC-4; rabbit polyclonai anti-N-cad- 
herin. After rinsing, appropriate fluorophore-conjugated second antibodies 
in PBS and 2% BSA were applied for 1 h followed by rinsing in PBS. The 
slides were coverslipped with a glycerol and PBS mixture (1:2) containing 
p-phenylenediamine (0.3  mg/ml) to prevent fading.  All comparisons in 
staining intensity were made on tissue treated in the same manner and 
stained with identical dilutions of antibody, and were repeated at least three 
times. The sections were viewed and photographed with Kodak Tri-X Pan 
film with a Nikon Microphot microscope equipped with epifluorescence. 
Immuno-Electron Microscopy 
Dorsal thigh muscles and attached femur and pelvic girdles were dissected 
from dTC-treated and control embryos at  St 32,  35-36,  and  38,  rinsed 
quickly in calcium-free Tyrode buffer, and fixed while pinned in an extended 
position for 1 h with 4% formaldehyde and 0.2% glutaraldehyde in 0.13 M 
phosphate buffer, pH 7.4.  The muscles were removed, rinsed in 0.13  M 
phosphate buffer and embedded in 30 % albumin and 3 % gelatin. The em- 
bedded muscle was Vibratome sectioned transverse to the limb at 50-100 
/zm, and the sections were collected in TBS, pH 7.6, and imrnunostained 
for NCAM, PSA, or N-cadherin as floating sections. 
Sections were processed for NCAM or N-cadherin immunocytochemis- 
try with the indirect enzyme method of Sternberger, as previously described 
(Fredette and Landmesser, 1991a). All of the immunoreagents were diluted 
in TBS. Briefly, the reaction steps were: (a) blocking for 1 h in 5 % normal 
rabbit serum; (b) incubation for 48-72 h at 4°C with 1:100 mAh 5E or 1:50 
mAb GC-4 in 1%  normal rabbit serum; (c) incubation for 1 h  in rabbit 
anti-mouse (1:50) with 1% normal rabbit serum; (d) incubation for 1 h in 
mouse clono-PAP (1:100) with 1% normal rabbit serum; (e) steps 3--4 were 
repeated to enhance the signal. Some sections were processed for N-cad- 
herin immunocytochemistry with a rabbit polyclonai antibody according to 
the same protocol with the following exceptions: rat serum was used as the 
blocking serum, rabbit anti-N-cadherin was used as the primary antibody, 
goat anti-rabbit (Sigma Immunochemicals) was used as the second antibody 
and the PAP was raised in rabbit. Immunocytochemistry for PSA was per- 
formed by the direct enzyme method with rabbit serum as the blocking 
agent, 1:200 mAb 5A5 ascites as the primary antibody and goat anti-mouse 
IgG (Sigma Immunochemicais) as the second antibody. Immunostaining in 
all three groups of sections was made visible and electron dense by reacting 
the sections in 0.05 % diaminobenzidine and 0.001% hydrogen peroxide for 
10-15 rain. The immunostained sections were osmicated, dehydrated and 
embedded in a TAAB/EPON resin mixture according to standard electron 
microscopy protocols, and thin sections were cut, collected on Formvar- 
coated slot grids, stained with 0.2% lead citrate, and viewed with a Philips 
301  transmission electron microscope. 
Enzymatic Removal of GPI-linked NCAM 
St 38 thigh muscles were homogenized in 50 mM Hepes buffer, pH 7.4, with 
protease inhibitors (100 #g/ml leupeptin, 1 mM EDTA, 900 TIU aprotinin, 
2 mM PMSF) and 15 mM NaCI, were pelleted and washed to remove solu- 
ble proteins, and then separated into three equal portions. One sample re- 
ceived 5 U/ml of phosphatidylinositol-specific phospholipase C  (PI-PLC, 
from Bacillus cereus; Sigma Immunochemicals), and the other two samples 
served as controls containing either no enzyme or enzyme plus 5  mM 
ZnC12 which specifically blocks phosphatidylinositol hydrolysis by PLC 
(Sundler et al., 1978). The samples were incubated for 2 h at 37°C, the solu- 
ble (supernatant) and insoluble (pellet) fractions were separated by centrifu- 
gation, and the pellets were rinsed and resuspended in Hepes extraction 
buffer containing 1% NP-40 and protease inhibitors. The protein concentra- 
tions of the pellets and corresponding supernatants were measured by the 
Pierce BCA method (Pierce, Rockford, IL), and when necessary, both pellet 
and corresponding supernatant samples were equally diluted. The resulting 
samples were  then analyzed by  either ELISA or  SDS-PAGE  immuno- 
blotting. 
ELISA Analysis of  PSA-NCAM 
Polysialic acid on PI-PLC-solubilized and PI-PLC-resistant NCAM was 
analyzed in St 38 muscle by an ELISA sandwich assay in two separate ex- 
periments,  each  consisting of tissue pooled  from  four embryos.  Anti- 
NCAM antibody was absorbed onto the wells of Pro-Bind plates by over- 
night incubation of 2 #g/ml of 5E antibody in 50 mM sodium bicarbonate. 
The wells were rinsed with PBS, and blocked with 1% BSA in PBS. Follow- 
ing PI-PLC treatments (above), pellet and corresponding supernatant sam- 
ples were serially diluted to between 2 and 200 #g/ml. In parallel sets of 
wells, the samples were assayed for either NCAM with a rabbit anti-NCAM 
polyclonal  antibody  and  HRP-conjugated goat  anti-rabbit  (Sigma  Im- 
munochemicals) as second antibody, or for PSA with 5A5 ascites and HRP- 
conjugated goat anti-mouse IgM (Sigma Immunochemicals) as second anti- 
body. Both 5A5 and 5E were used at concentrations that ranged from 1:500 
to  1:5,000,  and both second antibodies were used at  1:10,000  dilutions. 
Wells  lacking  muscle extract,  but processed with either 5A5  or rabbit 
anti-NCAM immunoreactions served as controls for non-specific staining. 
Immunostaining was detected by 0.04%  o-phenylenediamine and 0.01% 
hydrogen peroxide in 0.1 M citrate buffer. The results from two separate ex- 
periments are presented in Table I where the values of NCAM are expressed 
in absorbance units. PSA absorbance values are expressed in relation to the 
amounts of NCAM measured in parallel wells (PSA/NCAM) and these 
values  were  used to  calculate  the percentage of polysialylated NCAM 
released from the muscle extracts of PLC treatment according to the follow- 
ing  formula:  100  x  (PSApellet/NCAMpellet)/(PSApelIet/NCAMpelIct) + 
(PSAsupernatant/NCAM  supernatant)  ) • 
SDS-PAGE Immunoblotting 
Thigh muscles of either control or dTC-treated embryos between St 28 and 
39 were dissected and tissue from each stage was pooled until about 500 
tzL was obtained (usually three to five embryos at st 28-32, 3 at st 35, and 
1-2 at st 38-40).  The tissue was homogenized in Hepes extraction buffer 
containing 1% NP-40 and protease inhibitors (see above). The solubilized 
protein concentrations were determined (BCA method; Pierce) and adjusted 
to 1-2 ttg/ml. Some of the extracts were divided into two sets, and one of 
these sets was adjusted to pH 5.5 and incubated for 1 h at 37°C with neur- 
aminidase (0.08  U/ml, type X  from Clostridium perfringens; Sigma Im- 
munochemicals) to remove sialic acid while the other was incubated with 
buffer alone. In other cases, a third portion of the extract was incubated for 
1 h at 370C in 600 U/ml endoneuraminidase purified from phage infected 
bacteria according to previous procedures (Rutishauser et al., 1985) to re- 
move polysialic  acid.  SDS  sample buffer containing dithiothreitol was 
added to each sample and the proteins separated by SDS-PAGE according 
to the Laemmli method (Laemmli, 1970) on a 6% gel. The proteins were 
transferred onto Immobilon P membranes, which were immunostained for 
either NCAM with mAb5E or for PSA with mAb5A5 and appropriate alka- 
line phosphatase-conjugated second antibodies, which were visualized with 
the BCIP/NBT  method.  Pyruvate  kinase,  fructose 6-phosphate kinase, 
B-galactosidase,  and  tx2-macroglobulin  stained  with  Bromphenol  blue 
served as molecular weight standards. The different isoforms of NCAM are 
Table L  Polysialic Acid on Pl-linked NCAM 
Control  PI-PLC  PI-PLC  +  ZnCI~ 
Pellet  Supematant  Pellet  Supernatant  Pellet  Supernatant 
N-CAM  93,1  6.9  68.5  31.5  100  0 
87.5  12.5  73.3  26.7 
PSA  97.2  2.8  61.7  38.3  100  0 
97.1  2.9  55.3  44.7 
The quantity of PSA on PI-PLC extractable NCAM was measured by ELISA. 
St 38 hindlimb muscle membranes incubated with PI-PLC were separated  by 
centrifugation  into solubilized proteins in the supematants  and insoluble  pro- 
teins remaining in the pelleted membranes, homogenized with non-ionic deter- 
gent, and incubated in ELISA wells precoated with 5E antibody to NCAM. In 
parallel plates, the quantities  of NCAM and of PSA associated  with the 5E- 
bound NCAM were measured with rabbit  anti-NCAM and 5A5  antibodies, 
respectively,  and the appropriate  HRP-conjugated  second antibodies.  After 
reaction  of the HRP with o-phenylene diamine,  absorbance units were ex- 
pressed as a  percentage  of the total  absorbance  measured  for each sample 
(pellet +  supernatant).  Control samples were provided by incubation in carrier 
alone (Control) or by inhibition of PI-PLC with ZnC12 (ZnC12 +  PI-PLC). 
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lecular weights after desialylation with neuraminidase. 
For the experiments  presented in Fig. i3, non-enzyme-treated  St 38 mus- 
cle detergent extracts were run on 6% polyacrylamide slab gels. The gels 
were cut into two portions at the 165-kD position, as determined by NCAM 
immunoblotting of flanking regions of the gel, and the proteins were elec- 
troeluted out of the two portions. The samples were concentrated about 
100-fold,  0.1% bovine serum albumin was added, and SDS was removed 
by passing the samples over Extracti-gel D columns (Pierce). The protein 
concentrations were determined, split into two aliquots, one of which was 
desialylated with neuraminidase, and then both samples were processed for 
NCAM and PSA immunobiot analysis as described above. The experiment 
was performed twice on different tissue samples and both gave identical 
results. 
Quantities of  the NCAM isoforms relative to total NCAM within samples 
were obtained by scanning  immunoblots with a  Shimadzu scanner. The 
resulting spectral densities for each NCAM isoform were expressed as per- 
centages of the total density measured within each gel lane. All measure- 
ments were made from gel lanes loaded with 5 ttg total protein, and in order 
to ensure that the relative quantity of any of the isoforms was not underesti- 
mated due to saturation of  the immunologic or enzymatic reactions used to 
detect NCAM, measurements were also made from lanes containing 2.5, 
10, and 15 #g of protein obtained from St 38 muscle. In all of these cases, 
the relative proportions of  the NCAM isoforms remained equivalent (within 
+/-2%). 
Results 
lmmunocytochemical Comparison of  Adhesion 
Molecule and Polysialic Acid Expression in Normal 
and Activity-blocked Muscle 
N-cadherin  and NCAM are known to be expressed in de- 
veloping chicken muscle throughout primary and secondary 
myogenesis. Expression  of both is down-regulated at late 
embryonic stages (Tosney et al., 1986; Covault and Sanes, 
1986a,b; Hahn and Covault, 1992), and in both late develop- 
ment and adult muscle their expression can be altered by 
nerve activity. In addition, neuromuscular blockade late in 
embryonic development (St 39-42)  results in an increase in 
N-cadherin  mRNA  (Hahn  and Covault,  1992). However, 
these studies did not determine if activity plays any role dur- 
ing earlier developmental stages. Therefore we first evalu- 
ated the effects  of  nerve activity on CAM expression through- 
out  primary  and  secondary  myogenesis by  comparing 
N-cadherin  and NCAM immunocytochemistry  in chicken 
hindlimb muscles that developed in the presence or absence 
of functional activation by nerve. Spontaneous motoneuron- 
evoked muscle contractions, normally beginning by stage 27, 
were blocked with daily in ovo injections of dTC (Dahm and 
l.xtndmesser, 1988), and frozen cryosections of the activity- 
blocked  and  stage-matched  control  hindlimbs  were  im- 
munofluorescently  stained  with antibodies  that recognize 
N-cadherin, all forms of the NCAM polypeptide, or NCAM 
PSA. Since we had previously characterized  primary and 
secondary  myogenesis in the chicken  iliofibularis muscle 
(Fredette and Landmesser, 1991a,b), this muscle was chosen 
as the focus for the present study. 
While immunofluorescence microscopy allowed us to de- 
tect differences in the overall levels of  expression of  adhesion 
molecules, the resolution was inadequate to determine if ex- 
pression was limited to specific cell types at certain develop- 
mental stages (myoblasts, primary myotubes, or secondary 
myotubes).  These  cells  interact  at precise  developmental 
stages within clusters, and the interactions include myoblast 
proliferation and fusion, as well as separation of maturing 
myotubes from the clusters.  Descriptions of these interac- 
tions during development have been provided at the ultra- 
structural level (Kelly and Zacks,  1969; Kikuchi and Ash- 
more, 1976; Ontell, 1977; Ross  et al., 1982; Duxson, 1989), 
including  those  in the  normal and  chronically  paralyzed 
iliofibularis muscle  (Fredette  and Landmesser,  1991a,b). 
Therefore, immunoelectron microscopy with antibodies to 
N-cadherin, NCAM, and PSA was performed to determine 
if the distribution of these adhesion molecules on cell sur- 
faces could help to explain either the normal interactions 
between ceils within a cluster, or the dTC-induced pertur- 
bations  of these  interactions  (Fredette  and  Landmesser, 
1991b). 
N-Cadherin 
N-cadherin expression was observed using two different anti- 
bodies: the monoclonal antibodies GC-4 (Volk et al., 1990) 
and a rabbit  polyclonal antibody  (kindly provided by M. 
Takeichi),  both  of which  gave the  same  results.  Intense 
N-cadherin immunofluorescenee  staining, visoaliTed  in Fig. 1 
by the GC-4 antibody, was observed in the iliofibularis mus- 
cle as well as in other hindlimb muscles during primary myo- 
genesis (Fig. 1 A; between St 27 and St 35). It then decreased 
throughout  secondary  myogenesis which  begins  at St  35 
(Fig. 1 C). This pattern of N-cadherin immunofluorescence 
in control muscle confirms observations recently made by 
Hahn and Covault (1992) with the NC-2 antibody of  Takeichi 
(Hatta and Takeichi, 1986). By St 40 only a few myofibers, 
possibly  corresponding  to slow tonic  fibers described  by 
Hahn and Covault (1992), remained N-cadherin positive (not 
shown). In dTC-treated muscles, N-cadherin immunostain- 
ing was also intense throughout primary myogenesis (Fig. 
1 B), and decreased during secondary myogenesis  (Fig. 1 D). 
However, at all stages investigated (St 30-40), staining inten- 
sity was always greater in the dTC-treated muscle than in the 
stage-matched control muscles, and by stage 35 was substan- 
tially more intense (compare (Fig. 1, C and D). This differ- 
ence was maintained until St 40, when N-cadherin was also 
down regulated in the dTC-treated muscles. Therefore, the 
down regulation of  N-cadherin expression appeared to be de- 
layed, but not abolished in the absence of  motoneuron activa- 
tion of developing myotubes, dTC treatment produced  no 
visible  alterations  in  N-cadherin  immunostalning  in  the 
sciatic or intramuscular nerves, which as described for con- 
trol hindlimbs by Hahn and Covault (1993), was extremely 
low in the intramuscular nerves, but high on bundles of  axons 
in the sciatic nerve which resulted in the patchy appearance 
seen in Fig.  1 (C and D). 
Myotubes were characterized with electron microscopy by 
the presence of myofibril bundles, and during both primary 
and  secondary  myogenesis, a  nonuniform  distribution  of 
N-cadherin was observed on myotube surfaces. As shown for 
St 31 (Fig. 2, A and B) and 38 (Fig. 2 C), N-cadherin im- 
munoreaction product was most abundant on the regions of 
plasma membranes  (asterisks) that form close appositions 
between  primary myotubes  (identified by  their  large  di- 
ameter and arrangement of myofibrils at the cell periphery) 
and the smaller and electron-dense myoblasts or newly de- 
veloping myotubes. However, it was reduced or absent from 
the appositions between more mature myotubes (Fig. 2, ar- 
rows). During primary myogenesis (St 31) and at the onset 
The Journal  of Cell Biology,  Volume 123, 1993  1870 Figure 1. Comparison of N-cadherin immunofluorescence in developing hindlimb muscles of control (A and C) and in dTC-treated (B 
and D) chick embryos. (.4 and B) Iliofibularis (IF) muscle and sciatic nerve trunks (SN) at St 31 during primary myogenesis. (C and D) 
View of the iliofibularis muscle, and sciatic nerve at St 35 during the onset of secondary myogenesis. N-cadherin immunostaining is more 
intense in the dTC-treated muscle at both stages, and the intensity difference is greater at St 35, while no intensity differences are apparent 
in the sciatic nerve. Intramuscular nerves in the iliofibularis muscle (arrows)  are weakly N-cadherin positive in both cases. P/T, posterior 
iliotibialis muscle. Bar, 200/~m. 
of secondary myogenesis (St 35, Fig. 3 B), mature and form- 
ing myotubes and myoblasts were observed with N-cadherin 
on their free surfaces, but by St 38 (Fig. 2 C) this was greatly 
reduced,  reflecting  what  had  been  observed  with  im- 
munofluorescence (Fig. 1 C). In addition to the staining ob- 
served on muscle cell profiles, N-cadherin reaction product 
was also observed on the extracellular surfaces of fibroblasts 
(which were large, only loosely associated with the myotube 
clusters, and which contained abundant polyribosomes and 
rough endoplasmic reticulum), and on extracellular matrix 
material containing collagen fibrils. 
EM localization of N-cadherin in activity-blocked muscle 
showed that in addition to the overall increase in N-cadherin 
expression observed by immunofluorescence, there was an 
obvious alteration in its distribution. In st 35 control muscles 
N-cadherin was low or absent on the apposed surfaces of 
more mature myotubes (Fig. 3 B), whereas in dTC-treated 
muscle intense N-cadherin staining was present at these ap- 
positions (Fig.  3 A, asterisks). 
NCAM 
Although N-cadherin immunofluorescence decreased dur- 
ing  secondary myogenesis,  immunofluorescence for total 
NCAM remained intense until after St 39 (Fig. 4, A, C, and 
E), when it begins to decrease (Tosney et al., 1986; Covault 
and Sanes, 1986). In contrast to the effect of dTC treatment 
on  N-cadherin  expression,  immunofluorescence  did  not 
reveal any obvious differences in total NCAM  expression 
during most of myogenesis.  As in control muscle, immu- 
nofluorescence remained bright until St 39 when NCAM ex- 
pression is down regulated (Fig. 4, B, D, and F). However, 
by St 38 (Fig. 4, EandF), a slightly lower intensity of immu- 
nostaining was observed in the activity-blocked muscles. As 
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the sciatic and intramuscular nerves of control muscle was 
unaltered. 
Despite the apparent lack of change in NCAM expression 
that was observed at the light microscopic level during nor- 
mal development, EM analysis revealed a change in its distri- 
bution.  Throughout development NCAM  immunoreaction 
product was observed on both the free and apposed surfaces 
of primary myotubes, myoblasts, and fibroblasts (Fig. 5, A 
and B). However, at early stages (st 31),  some portions of 
muscle cell membranes that shared appositions with other 
cells within clusters were not immunopositive (see for exam- 
pie  Fig.  9  B,  arrows),  but  these  unstained  portions  de- 
creased, so that by St 38 uniform NCAM staining was ob- 
served on all surfaces of all cell types within the cluster (Fig. 
6, A and B). In addition to NCAM immunostalning on the 
myotube surface, immunoreaction product was observed on 
the  internal  surfaces  of small  intracellular vesicles  (Fig. 
6 B). Some NCAM-positive vesicles were also observed in 
contact with the cytoplasmic surface of the cell membrane, 
while others had membranes continuous with the cell mem- 
brane. Both coated and non-coated NCAM-positive vesicles 
were observed, and some of the non-coated vesicles formed 
complexes, resembling the caveolae described by Yamada 
(1955) in epithelial cells and by Franzini-Armstrong (1991) 
in developing skeletal muscle.  Such vesicles could be in- 
volved in NCAM's delivery to or removal from the cell sur- 
face, or they could be parts of forming T-tubules, which are 
known to express NCAM (Covault and Sanes,  1986). Like 
N-cadherin,  NCAM was also observed on the surfaces of 
non-muscle cells such as fibroblasts, intramuscular axons and 
Schwann cells,  as well as on what appeared to be ECM- 
containing  collagen  fibrils.  Some  of  this  extraceUular 
NCAM may have been due to interactions between heparin 
sulphate proteoglycogan contained in the extracellular mate- 
rial and the heparin sulphate-binding site on NCAM  (see 
Cole et al.,  1986). 
As  with  immunofluorescence, EM  analysis  (Fig.  7)  of 
dTC-treated muscles did not reveal any perturbation in the 
distribution of NCAM, since NCAM was observed on both 
the free and apposed surfaces of myotubes and myoblasts, as 
was the case with control muscle. 
Polysialic Acid 
Unlike the relatively uniform expression of  total NCAM, the 
amount of PSA associated with NCAM exhibited a striking 
temporal regulation during development (Fig. 8). During the 
period in which total NCAM immunostaining remained in- 
tense and invariant (St 28-39),  PSA immunofluorescence 
was initially visible only on some myotube surfaces at low 
intensity levels, (St 28, not shown). Staining then increased 
at a slow rate throughout primary and early secondary myo- 
genesis,  until  beginning  at  St  37  (Fig.  8  A)  it  increased 
sharply to peak at St 38 (Fig. 8 C), and then rapidly declined 
at St 39 (Fig.  8 E).  While the overall expression of total 
NCAM was only slightly affected by activity blockade, PSA 
expression was  dramatically altered.  Immunofluorescence 
with mAb 5A5 revealed that activity blockade virtually abol- 
ished the presence of PSA on myotube surfaces (Fig. 8, B, 
D, and F), even at St 38 when PSA was dramatically up- 
regulated in the control muscle. This effect  was not particular 
to the iliofibularis muscle, as it occurred in other hindlimb 
muscles as well. However, the effect was restricted to myo- 
tubes,  since immunostaining for PSA in the sciatic nerves 
of  the dTC-treated embryos did not differ from that in control 
muscle (Fig. 8 C). Although activity blockade produces an 
up-regulation of polysialylated NCAM  in nerve trunks  at 
early embryonic stages (St 2%32) (Landmesser et al., 1991), 
by St 35 PSA expression on intramuscular nerves had de- 
creased to very low levels in both control and dTC-treated 
embryos, and no difference in staining intensity was observed. 
Electron microscopy revealed that polysialylated NCAM 
displayed an unusual cellular distribution: while total NCAM 
was expressed on all surfaces of muscle cells, polysialylated 
NCAM was always restricted to their free surfaces. At St 31, 
when PSA levels were observed to be low by immunofluores- 
cence, only portions of  the free surfaces of muscle cells were 
immunopositive (Fig. 9 A), PSA was notably absent from 
regions between closely apposed cells (arrows Fig. 9 A, ar- 
rows). Although NCAM was also not yet uniformally dis- 
tributed,  it was present over more of the cell surface than 
PSA (compare Fig. 9, A and B). Between St 31 and 38, PSA 
immunostalning became more extensive over the free sur- 
faces of cells, so that by St 38, when PSA expression peaks, 
entire clusters appeared to be encapsulated by PSA (Fig. 
9 C). As at St 31, PSA was virtually excluded from the ap- 
posed surfaces of cells within clusters; however staining of- 
ten extended from the free surfaces a short distance, espe- 
cially between cells  at the  edges of the  cluster  (Figs.  9, 
Cand 10A, asterisks). In contrast, total NCAM was by now 
abundant  on  all  cell  surfaces,  including  those  between 
closely apposed myotubes (Fig.  10 B). 
The absence of PSA from cell appositions within clusters 
did not appear to be an artifact due to a failure of the im- 
munoreagents to penetrate to these  surfaces,  because al- 
though the 5A5 antibody used to detect PSA was of IgM iso- 
Figure 2.  Electron microscopic localization of N-cadherin on developing myotubes. (A) Myotube clusters in St 31 iliofibularis muscle. 
N-cadherin is present on the free surfaces of  primary myotubes (P) and electron-dense blast cells (B) and where primary myotubes appose 
blast cells (asterisk). N-cadherin is low or excluded from regions where primary myotubes closely appose each other (arrows). (B) Higher 
magnification view of St 31 muscle to show an N-cadherin-positive region where the cell membranes of a blast cell (B) and a primary 
myotube (P) appose each other (asterisk), and an N-eadherin negative region where two primary myotubes appose each other (arrow). 
(C) St 38 iliofibularis muscle during secondary myogenesis, when N-cadherin expression is down regulated. N-cadherin immunostaining 
persists on portions of  the free surfaces of  muscle cells, but is most dense at appositions between blast cells and myotubes (asterisk). Arrows 
indicate expanses of membrane that form appositions between a primary and secondary myotube in a cluster (left), and between two second- 
ary myotubes shown on the right (S) that have separated from a cluster. In these regions N-cadherin reaction product is present, but sparser 
than at appositions with blast ceils (asterisk). Bars, 2 t~m. 
Fredette et al. Adhesion Molecule  Regulation during Myogenesis  1873 Figure 3. Evaluation of N-cadherin distribution in dTC-treated iliofibularis muscle at St 35, when N-cadherin immunofluorescence  is in- 
creased over control levels. (A) Portion of an extremely large myotube cluster, characteristic  of those in activity blocked muscle, showing 
five myotubes that are N-cadherin positive not only on their free surfaces, as observed in control muscles, but also on most of their apposed 
surfaces  (asterisks).  One region between two myotubes (arrow) is N-cadherin negative, but these regions were rarely found in the dTC- 
The Journal of Cell Biology, Volume 123, 1993  1874 Figure 4. NCAM immunofluorescence in control (A, C, and E) and dTC-treated  (B, D, and F) developing muscle with 5E antibody which 
recognizes all protein isoforms of NCAM. (A and B) Staining  at St 31 during primary myogenesis;  (C and D) at St 35 during the onset 
of secondary myogenesis; (E and F) at St 38 during secondary myogenesis. The myotubes, intramuscular nerves (arrows) and sciatic nerve 
trunks (SN) of the control embryos are intensely  immunopositive through St 38. Staining  is similar to control in the dTC-treated  embryos 
until  St 35, but by St 38, immunostaining in the dTC-treated  muscle (F) is somewhat less  intense  than in the control embryo (E). IF, 
iliofibularis  muscle; P/Z,  posterior iliotibialis  muscle.  Bars: (A and B)  100/~m; (C and D)  150/~m;  (E and F) 200/~m. 
treated muscles.  (B) Plasma membranes of myotubes and blast cells in a control iliofibularis muscles are also N-cadherin positive on their 
free surfaces, and at regions where primary myotubes appose newly formed secondary myotubes or myoblasts (asterisks),  but are not stained 
where more mature primary myotubes appose each other (arrow).  Bars: (A) 2/~m; (B)  1.4/~m. 
Fredette et al. Adhesion Molecule Regulation during Myogenesis  1875 Figure 5. Distribution of total NCAM in the iliofibularis muscle. (A) During primary myogenesis (st 31), 5E immunoreaction product for 
total NCAM is present on free and apposed plasma membrane surfaces of two primary myotubes (P) and several blast cells (B). (B) Low- 
magnification electron micrograph of NCAM localization in a myotube cluster at the onset of secondary myogenesis (st 35). The surfaces 
of primary myotubes (P), forming secondary myotubes (S), and blast cells (B) of two clusters are nearly entirely NCAM positive, although 
portions of apposed surfaces within the cluster contain very little NCAM (arrows). Bars: (A) 2 #m; (B) 3 #m. 
The Journal of Cell Biology,  Volume 123, 1993  1876 Figure 6.  The distribution of total NCAM becomes uniform on cell surfaces during secondary myogenesis. (A) NCAM immunostaining 
on primary (P), secondary (S), and blast (B) muscle cells within a cluster,  and on two nearby secondary myotubes that are no longer 
associated with a cluster (arrow). By St 38, all muscle cell types are NCAM positive along all of their surfaces, and NCAM-negative regions 
observed at earlier stages are no longer visible. (B) NCAM is present not only extraceIlularly  on free and apposed plasma membranes, 
but also intracellularly  on the internal surfaces of large and small non-coated'  vesicles or calveolae  (arrows). A coated vesicle indicated 
by the arrowhead  also contains NCAM immunoreaction  product.  Double arrow points to a caveolae complex that is continuous with the 
plasma membrane. Bars,  (.4) 2.0 #m; (B) 0.64 #m. 
Fredette et al. Adhesion Molecule Regulation during Myogenesis  1877 Figure  7.  The  distribution  of 
NCAM is not perturbed by dTC 
treatment. Electron micrograph of 
the iliofibularis muscle of a St 38 
dTC-~  embryo  containing  myo- 
tubes that are NCAM positive on 
their  free  and  apposed surfaces. 
The myotubes  also contain NCAM- 
positive  vesicles (arrow). Bar, 
0.5 #m. 
type and therefore large, the same restricted distribution was 
found with another anti-PSA antibody of IgG isotype (Fig. 
10 C). Since the 5E antibody used to visualize the NCAM 
polypeptide is also an IgG, and was detected on all cell sur- 
faces, we concluded that the absence of 5A5 immunoreaction 
product at cell-cell appositions was not an artifact of poor 
antibody penetration. 
Since  no  PSA  immunostaining was  observed  in  dTC- 
treated muscle at the light microscope level, we did not study 
PSA in these muscles at the EM level. 
In summary then, chronic paralysis of developing muscles 
produced three alterations in the normal expression of adhe- 
sion molecules as detected by immunofluorescence and im- 
munoelectron microscopy: (a) N-cadherin expression was 
enhanced  and  its  down  regulation  delayed;  (b)  a  dTC- 
induced decrease of NCAM levels was detected after St 38; 
and (c) polysialylated NCAM, which was restricted to the 
free surfaces of myotubes, was not expressed in the dTC- 
treated muscles, despite the continued expression of total 
NCAM. 
Immunoblot Analysis of NCAM 
Isoforms in Developing Control and 
dTC-treated Muscle 
Since, mAb 5E does not distinguish among the different iso- 
forms of NCAM, it is possible that although overall NCAM 
expression  was  only  slightly affected by  dTC  treatment, 
larger changes in the expression of individual isoforms may 
have occurred. While all three major NCAM isoforms have 
been shown to be capable of mediating neurite adhesion and 
outgrowth when transfected into 3T3 ceils (Doherty et al., 
1990), the possibility exists that the different isoforms could 
be playing different roles during more complex developmen- 
tal events in intact tissue.  For example,  the  switch from 
transmembrane isoforms to a GPI-linked isoform has been 
suggested to play a role in myoblast fusion (Dickson et al., 
1990).  It is also possible that the different isoforms could be 
differentially  sialylated, providing the possibility of targeting 
PSA to specific cell surfaces. It is known from other systems 
that such targeting is associated with GPI linkages (Dotti et 
al.,  1991; Powell  et  al.,  1991; Dotti  and  Simons,  1990; 
Lisanti et al., 1988; Brown et al., 1989).  For these reasons 
we  examined the molecular weight forms of NCAM  ex- 
pressed during muscle development in the presence and ab- 
sence  of nerve  activity  and  determined  which  of these 
NCAM isoforms contained PSA. 
The different isoforms of NCAM expressed during pri- 
mary and secondary myotube formation were examined with 
SDS-PAGE  combined with immunoblot analysis (Fig.  11). 
Thigh muscle homogenates from embryos at St 28 and St 32 
(during different stages of primary myogenesis), St 35 (at the 
The Journal of Cell Biology, Volume  123, 1993  1878 Figure 8. Immunofluorescence for polysialylated NCAM with PSA-specific rnAb 5A5 in control (A, C, and E) and dTC-treated (B, D, 
and F) developing muscle. (A, and B) St 37. (C and D) St 38. (E and F) St 39. A rapid and transient upregulation of polysialylated NCAM 
occurs between St 37 and 39 in control muscle, but in dTC-treated muscle, virtually no polysialylated NCAM is expressed on myotubes, 
although immunostaining of  the sciatic nerve remains identical to that in control embryos. IF, iliofibularis muscle; P/T, posterior iliotibialis; 
SN, sciatic nerve. Bar, 300 ~m. 
onset of secondary myogenesis), and St 38 and 40 (when sec- 
ondary myogenesis is well underway) contained NCAM of 
5 different molecular weights when desialylated with neur- 
aminidase:  180,  155,  145,  and 130 kD, and in many but all 
of the samples,  120 kD (Fig.  11 A, lanes 2-6).  In order to 
determine which of these may have been due to the presence 
of intramuscular nerve in the muscle samples, sciatic nerve 
homogenates were examined, and found to contain approxi- 
mately equal amounts of 180-,  145-,  and  120-kD NCAM. 
Since the muscle samples contained only a minor amount of 
180-kD NCAM,  which is considered to be nerve specific, 
(but see Tassin et al.,  1991),  we concluded that only a very 
minor portion of the 145- and 120-kD isoforms could be due 
to contamination by nerve. 
The predominance of the different molecular weight iso- 
forms of NCAM  were observed to vary according to de- 
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copy for polysialylated NCAM with 
mAb  5A5. (.4) I.x~-rnagnification 
view of the  patchy  distribution  of 
polysialylated  NCAM  on  the  free 
surfaces of  myotube clusters at St 31. 
Patches of PSA were usually located 
on regions  of cell  membranes that 
were close to, but not congruent with 
other cells (asterisk).  Nearly all ap- 
posed surfaces are PSA negative (ar- 
rows).  (B) A  comparison  with  the 
distribution of total NCAM at St 31 
shows that although total NCAM is 
also  expressed  non-uniformly,  its 
distribution  is  more extensive than 
that of PSA. Arrows show NCAM- 
negative patches  of apposed  mem- 
branes. (C) At St 38, when immuno- 
fluorescence for PSA peaks, 5A5 re- 
action product remains restricted  to 
the cluster periphery, forming a gly- 
cocalyx-like  coat that  encloses  the 
entire myotube duster. However, as 
at earlier stages, reaction product is 
not present on most apposed surfaces 
within the cluster (arrows), except at 
some regions near the periphery of 
the cluster (asterisks).  PSA reaction 
product  is  also  present  scattered 
throughout the extracellular matrix. 
Bars:  (A) 3  #m;  (B) 2.4  #m;  (C) 
2.7 #m. 
velopmental stage (in Fig.  11 A, compare lanes 2-6). At St 
28, most of the NCAM present in muscle had an apparent 
molecular weight of 145 kD, and this remained the predomi- 
nant isoform through St 35. However, by St 38 expression of 
the 130-kD NCAM had increased with respect to the other 
forms, and by ST 40 it had become the major isoform. At 
the same time, the proportions of NCAM running at 145 and 
155 kD also decreased. In addition, the amount of the 145- 
kD isoform relative to the  155-kD isoform decreased after 
St 28, with both isoforms being equally represented by St 35. 
Following activity blockade (Fig. 11 B), the initial pattern 
of NCAM expression was unaltered.  Thus at St 28,  most of 
the NCAM was of the 145-kD isoform, and over the next sev- 
eral stages the other isoforms (155 and 130 kD) increased as 
in control muscle. However, the subsequent shift after St 35, 
in which the 130-kD isoform increases and the 145- and 155- 
kD isoforms decrease, did not occur in the dTC-treated mus- 
cle (compare the control Fig.  11  A,  lane 6  with the dTC- 
treated muscle Fig.  11 B, lane 3); instead the relative levels 
of expression remained similar to those observed at St 32. 
When the intensities of the different NCAM bands were 
compared within each immunoblot and expressed as a per- 
centage of the total NCAM (Fig.  11 C), in both control and 
dTC-treated muscle at St 28, the 145-kD NCAM was found 
to comprise about 60% of the total muscle NCAM while the 
130-kD form comprised less than 10%. However, while the 
proportion of  the 145-kD form had decreased in control mus- 
cle by St 39 to 25%  and that of the  130-kD form had in- 
The Journal of Cell Biology, Volume 123,  1993  1880 Figure 10.  Comparison of total and polysialylated NCAM immunostaining in St 38 iliofibularis  muscle. (A) Portion of a myotube cluster 
with 5A5 reaction product for PSA predominantly located at the free surfaces. PSA is also seen penetrating for short distances between 
closely apposed cells near the periphery of the cluster (asterisks). The shapes of the PSA-positive  cell profiles suggest that the cleft between 
them has formed by the separation of the upper cell from the other cells. No PSA is present on most of the apposed myotube surfaces 
(arrows). (B) Total NCAM, on the other hand, is present not only on the free surfaces of myotubes, but also on all of the apposed surfaces 
within the cluster (arrows).  (C) Immunostaining with an IgG isotype antibody against PSA produces the same distribution of reaction 
product (at the free surfaces of cells, but not at cell-cell appositions) as 5A5, which is an IgM class antibody. Therefore, the distribution 
pattern of PSA observed with 5A5 is not an artifact due to a failure of the larger IgM antibody to penetrate to cell surfaces within clusters. 
Bars: (.4) 0.5 #m; (B)  1 /zm; (C) 0.8/~m. 
Fredette et al. Adhesion Molecule Regulation during Myogenesis  1881 Figure 12. GPI-linkage  of the 130-kD NCAM form in control and 
dTC-treated  muscle.  St 38 muscle membranes were incubated  in 
buffer in the absence (lanes  1 and 2) or the presence (lanes 3 and 
4) of  phosphatidyl inositol-specific  phospholipase C (PI-PLC). The 
resulting soluble (lanes 2 and 4) and insoluble (lanes I and 3") frac- 
tions were separated and processed for NCAM Western blot analy- 
sis with 5E antibody.  Incubation of both control and dTC-treated 
muscle with PI-PLC resulted  in an increase  in the amount of 130 
kD (and some 120 kD) NCAM in the soluble fraction (lane 4), and 
an accompanying decrease in the amount of 130-kD NCAM in the 
insoluble  membrane fraction (lane  3),  as compared to the non- 
enzyme-treated membranes (lanes  1 and 2).  Calculated  Mr (kD) 
are indicated  on the left. 
Figure 11. Activity blockade prevents developmental  changes in the 
molecular weight isoforms of NCAM expressed  in hindlimb  mus- 
cles.  Neuraminidase-desialylated  proteins  extracted  with  NP-40 
from muscle or sciatic nerve homogenates were separated by SDS- 
PAGE  and  immunoblotted  with  5E  antibody  and  alkaline 
phosphatase-conjugated  secondary antibody.  (A) Western  blots of 
control embryo NCAM isoforms  in St 38 sciatic  nerve (SC, lane 
/) and in muscle at St 28, 32, 35, 38, and 40 (M, lanes 2-6, respec- 
tively)  stained  with  5E.  In lane  7,  St 38 muscle proteins  were 
processed  only  with  the  second  antibody  as  a  control  for 
nonspecific staining. Calculated (145 and 130 kD) and protein stan- 
dard Mr (210 and 116 kD) are shown on the left.  (B) 5E Western 
blots of St 28, 32 and 39 muscle NCAM (lanes 1-3, respectively) 
from dTC-treated  embryos. (C) Quantitative  representation  of the 
developmental  change in predominant NCAM forms. Densitomet- 
ric scans were made of NCAM immunoblots and the quantity of the 
145- (o) and the 130-kD (o) bands were expressed  as a percent- 
age of the total density of all muscle NCAM forms (155, 145, 130, 
and  120  kD).  Control muscle expresses  predominantly  145-kD 
NCAM at St 28, but after St 36 the 130-kD form becomes predomi- 
nant. In dTC-treated  muscle, the 145-kD form is also initially pre- 
dominant, but by St 32 the 145- and 130-kD forms are equally rep- 
resented.  Each point is the value obtained from a representative 
gel.  (D) Comparisons of the relative quantities  of NCAM isoforms 
at st 32 and st 38. Asterisks indicate significant changes (a decrease 
for 145-kD NCAM and an increase  for 130-kD NCAM) that oc- 
curred in the control muscle between  st 32 and 38 (P <  0.01, un- 
creased to over 55 %, in dTC-treated muscles, the 145- and 
130-kD isoforms remained equally represented after St 32, 
each comprising about 30% of  the total NCAM. A statistical 
analysis showed that a significant decrease in 145-kD NCAM 
and an increase in 130-kD NCAM occurred in control mus- 
cle between st 32 and 38, but that these changes did not occur 
in the dTC-treated muscle (Fig.  11 D). 
To determine which of  the isoforms of muscle NCAM cor- 
responded to extracellular lipid-linked NCAM, crude mus- 
cle membrane preparations were incubated in GPI-specific 
PLC (Knudsen et al.,  1989). GPI-PLC solubilized the 130- 
kD NCAM (and a minor quantity of the 120-kD NCAM) at 
all  stages when this isoform was expressed  (St 32,  35,  38, 
and 39), as shown in Fig. 12 for a St 38 muscle sample. How- 
ever,  GPI-PLC treatment never removed all of the  130-kD 
NCAM, and at St 38 when the abundance of this form was 
very high, only about half was solubilized by the enzyme. 
In studies of  other GPI-linked proteins a portion of  these pro- 
teins are also often resistant to PLC, apparently because they 
have  alternative  or  additional  linkages  to  the  membrane 
(Ferguson  et  al.,  1985;  Almquist  and  Carlsson,  1988). 
While we did not determine if such alternative linkages oc- 
curred  for the  130-kD  NCAM,  the  release  of NCAM by 
means other than via an effect on the GPI anchor (such as 
phosphatidyl choline hydrolysis or proteolysis)  were ruled 
paired t-test).  No differences  were detected  between  St 32 and 38 
in the dTC-treated  muscle.  Values are means  +  S.E.  from three 
separate  experiments.  * P  ~  0.01, unpaired t-test. 
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differentially  represented 
among the  molecular weight 
forms of NCAM. (A) Western 
blot analysis of St 38 hindlimb 
muscle extracts that were left 
fully glycosylated (lanes I and 
4),  or  treated  with  either 
endo-N (E-N)  to remove PSA 
(lanes 2 and 5) or neuramini- 
dase  (N)  to  further  remove 
sialic  acid  residues  (lanes 3 
and 6).  Lanes 1-3, immuno- 
staining for NCAM with 5E. Lanes 4-6, immunostaining for PSA-NCAM with 5A5. See text for description. (B) Demonstration of poly- 
sialic acid on nearly all of the 130-kD NCAM and on very little of the 145-kD NCAM. NCAM extracted from St 38 muscle was separated 
by SDS-PAGE, and the gel was cut into two parts at the 165-kD region. Proteins eluted from the two portions were either left glycosylated, 
or were desialylated with neuraminidase, and analyzed with 5E (lanes 1-6) and 5A5 (lanes 7-10) Western blotting. Non-treated (lane/) 
and enzyme-treated (lane 2) total muscle NCAM; non-treated (lanes 3 and 7) and enzyme-treated (lanes 4 and 8) NCAM eluted from 
the >165-kD portion of the gel. Non-treated (lanes 5 and 9), and enzyme-treated (lanes 6 and 10) NCAM from the <165-kD portion of 
the gel. Desialylation of the upper portion of the gel which contains PSA (lane 7) results in 155- and 130-kD NCAM, but very little 145-kD 
NCAM (lane 4), while the PSA-negative lower portion (lane 9) is only somewhat neuraminidase sensitive, producing 155 and 145 kD 
but no 130-kD NCAM. 
out by the ability of zinc chloride to completely inhibit the 
effect of the enzyme (see Table I). Furthermore the molecu- 
lar weight of the enzyme-solubilized NCAM (130 kD) was 
not smaller than that remaining in the membrane, as would 
have been expected had solubilization occurred by proteoly- 
sis. Although the amount of 130-kD NCAM was reduced fol- 
lowing dTC treatment, this too was removed from membrane 
preparations by PI-PLC as  in controls (Fig.  12,  compare 
lanes 3  and 4  in both control and dTC treated), indicating 
that it was also lipid linked. 
Polysialylation of  NCAM Isoforms 
Since the 130-kD NCAM isoform was considerably reduced 
in the dTC-treated muscles, the possibility that this form car- 
ried most of the PSA (and thus contributed to the absence 
of PSA in activity-blocked muscle) was explored in St 38 
muscle  when  PSA  levels  are  maximal.  Muscle  extracts 
treated with an endoneuraminidase that is  specific for the 
a-2,8 sialyl linkages in PSA, which we term endo-N (Finne 
et al., 1983; Acheson, 1991), and non-enzyme-treated mus- 
cle extracts were analyzed by SDS-PAGE and immunoblot- 
ting for NCAM or PSA.  NCAM from non-enzyme-treated 
muscle ran as a polydispersed band between 220 and 140 kD 
(Fig. 13 A, lane/), and PSA immunostaining occurred only 
above 155 kD (Fig. 13 A, lane 4). Following complete desial- 
ylation of NCAM with neuraminidase,  St 38 muscle pro- 
duced three distinct bands at 155,  145, and 130 kD (Fig.  13 
A, lane 3). Treatment with Endo-N, which leaves five sialic 
acid  residues,  resulted in  three bands  running  at  slightly 
higher molecular weights, as would be expected (Fig.  13 A, 
lane 2).  Since the bands running at the position of the two 
higher molecular weight bands could also be detected in the 
untreated sample (Fig.  13 A, lane/), and since this portion 
of the gel did not stain for PSA (Fig.  13 A, lane 4) we con- 
cluded that at least a portion of the desialo 145- and 155-kD 
NCAM isoforms did not contain PSA. In contrast, all of the 
130-kD isoform appeared to be polysialylated, since no band 
corresponding to that isoform was present in the native sam- 
ple (Fig.  13 A, lane/). Following endo-N treatment, a dis- 
tinct band appeared at 140 kD (Fig. 13 A, lane 2) and follow- 
ing complete removal of sialic acid with neuraminidase, this 
material ran at  130 kD (Fig.  13 A, lane 3). 
In confirmation of this conclusion, when native NCAM 
was eluted from the PSA-immunopositive portions of SDS- 
PAGE  gels  (i.e.,  that  running  above  165  kD)  and  then 
desialylated, mostly 155- and  130-kD isoforms, but only a 
minor portion of the 145-kD isoform, were obtained (Fig 13 
B,  lane 4).  Conversely, the lower molecular weight,  PSA- 
negative region of the gel contained only 155- and 145-kD 
NCAM, but no 130-kD NCAM (Fig. 13 B, lane 6). Together, 
these  observations  demonstrate  that  of the  four  desialo- 
molecular weight forms of NCAM expressed by embryonic 
muscle,  the  vast  majority  of the  130-kD  form  is  poly- 
sialylated, while most of the 145-kD form lacks PSA.  The 
155-kD  NCAM  appears  to  be  composed  of both  poly- 
sialylated and non-polysialylated forms expressed in nearly 
equal proportion. 
Further evidence that PSA is present on the 130 kD, PLC- 
extractable form of NCAM was provided by ELISA (Table 
I). Anti-NCAM absorbed onto ELISA wells was used to re- 
move NCAM  from crude membrane and  soluble  muscle 
fractions of St 38, PLC-treated muscle. The resulting quanti- 
ties of NCAM and associated PSA present in the two frac- 
tions were measured in parallel sets of wells with either a 
second antibody against NCAM or with anti-PSA. PLC solu- 
bilized more than 38 % of  the PSA present in the muscle sam- 
pies, along with over 25 % of the muscle NCAM,  while in 
control (non-enzyme-treated) samples only about 3 % of the 
PSA was  solubilized.  The higher proportion of PSA than 
NCAM released by PLC is indicative of the PLC-sensitive 
(and therefore, lipid-linked) form of NCAM carrying more 
PSA than the other NCAM  forms remaining in the mem- 
brane fraction. 
Discussion 
N-Cadherin Expression Is Correlated with Specific 
Stages of  Myogenesis 
Confirming the previously published results of Hahn and 
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during primary myogenesis and to be down regulated during 
secondary myogenesis. However,  by immunocytochemical 
analysis at the EM level, we have also been able to detail the 
pattern of N-cadherin expression on primary and secondary 
myotubes and on the myoblasts which give rise to them. Al- 
though N-cadherin expression was highest during primary 
myogenesis, its expression was not confined to primary myo- 
tubes since N-cadherin reaction product was observed on 
both primary and secondary myotubes, and particularly on 
the myoblasts giving rise to both of these. For both primary 
and secondary myotubes, N-cadherin expression was ini- 
tially high in myoblasts and young myotubes, and then de- 
creased as the myotubes matured. Myotubes formed in vitro 
have also been observed to undergo a progressive loss of 
N-cadherin as they mature (Mege et al., 1992). The presence 
of N-cadherin on the free surfaces of primary myotubes sug- 
gests that it may provide a permissive substrate for myoblast 
fusion. Thus N-cadherin adhesion might not only mediate 
fusion between myoblasts, as demonstrated in vitro by Knud- 
sen et al.  (1990b)  and Mege et al.  (1992),  but might also 
facilitate interaction between myoblasts and myotubes, in- 
cluding fusion and/or alignment. 
Whereas  the  free  surfaces  of maturing myotubes were 
N-cadherin positive, the surfaces that apposed other matur- 
ing myotubes lacked N-cadherin.  This apparent compart- 
mentalization of the membrane surfaces may play a role in 
allowing maturing myotubes to separate from each other. 
Such a role is strongly suggested by perturbations observed 
in the myotube clusters of dTC-treated embryos in which in- 
tense N-cadherin immunostaining was present between nearly 
all myotubes within these clusters, and these maturing myo- 
tubes failed to separate from the clusters. 
N-cadherin could become absent from membrane surfaces 
that appose other myotubes by a selective removal of the gly- 
coprotein from these surfaces by lateral movement in the 
membrane.  However,  it  is  probable  that  anchoring  of 
N-cadherin not only to the cytoskeleton, but also to the op- 
posite cell, might compromise its ability to move. Another 
possibility is that N-cadherin at these sites would undergo 
proteolysis or endocytosis. However, no N-cadherin-positive 
vesicles were observed to suggest the latter mechanism. Al- 
ternatively, the N-cadherin observed may be a cleavage prod- 
uct which is synthesized by and released from myoblasts and 
which becomes bound heterophilically to the free surfaces 
of the maturing myotubes which have already ceased to syn- 
thesize the  glycoprotein.  Active proteolytic fragments of 
N-cadherin have been found (Roark et al.,  1992),  and het- 
erophilic  interaction  of N-cadherin  with  another  CAM, 
R-cadherin, has been hypothesized by Redies et al. (1992). 
Another possibility is that in maturing myotubes, newly syn- 
thesized N-cadherin is not inserted into portions of  the mem- 
branes that form appositions with other cells. However, this 
would differ from the known localization of other cadherins 
such as E-cadherin at cell-cell contacts between epithelial 
cells (Shore and Nelson, 1991; Volk and Geiger, 1984) and 
desmogleins and desmocoUins at desmosomal junctions (Koch 
et al.,  1990;  Collins et al.,  1991). In any case, N-cadherin 
is clearly absent from these appositions in control muscles 
but  present  following activity blockade.  Thus,  whatever 
mechanism is responsible for the distribution of N-cadherin, 
it is regulated by muscle activity. In addition, the persistence 
of N-cadherin in these regions following activity blockade 
may contribute to the failure of myotubes to separate from 
the clusters. 
Regulation of NCAM Isoforms during Primary  and 
Secondary Myogenesis 
In denervated adult chicken muscle, which has been reported 
to express only 125-kD  NCAM (Covault et al.,  1986),  PI- 
PLC treatment solubilized NCAM that migrated as a single 
band corresponding to 130 kD (data not shown). Thus the 
130-kD NCAM in the present study apparently corresponds 
to lipid-linked NCAM referred to as 120- or 125-kD NCAM 
by other investigators (He et al., 1986; Covault et al., 1986; 
Dickson et al., 1987; Moore et al., 1987; Barton et al., 1988; 
Hemperly et al., 1986; Covault and Sanes,  1986; Cunning- 
ham et al.,  1987; Knudsen et al.,  1989, 1990b).  The 145- 
kD isoform which was not PLC-extractable corresponds to 
the transmembrane glycoprotein (Owens et al., 1987; Knud- 
sen et al., 1989, 1990b).  We also detected a second band at 
155 kD that was not removed by PI-PLC and was thus pre- 
sumably not lipid-linked.  The  145- and  155-kD  isoforms 
have recently been detected in chicken thigh muscle by an- 
other group (Yoshimi et al.,  1993),  where both have been 
judged to be transmembrane based on their reactivity with 
cytoplasmic domain-specific antibodies.  Some  molecular 
weight variations in these reported forms could also be due 
to variations in glycosylation other than sialylation or to 
differing phosphorylation states (Sorkin et al., 1984; Rutis- 
hauser et al., 1988; Hoffman et al., 1982). However Yoshimi 
et al. (1993) have reported that in chick thigh muscle from 
the same embryonic stages that we have studied, the 155-kD 
isoform has the muscle-specific domain (MSD) insert (Dick- 
son et al.,  1987),  whereas the  145-kD  isoform does not. 
They also reported that the MSD domain is present in the 
130-kD  isoform. 
In contrast to N-cadherin, myotubes continue to express 
NCAM until very late in development. However, while total 
NCAM expression did not vary during most of myogenesis, 
expression of specific isoforms was differentially regulated 
during primary and secondary myogenesis. Because anti- 
bodies that would distinguish among the different muscle 
NCAM isoforms were not available, we were unable to deter- 
mine if primary or secondary myotubes differentially ex- 
pressed the different isoforms on their surfaces. However, 
immunoblot analysis revealed that expression of the 130-kD 
lipid linked isoform increased markedly during secondary 
myogenesis. These findings are similar to those made by 
Covault and Sanes (1986),  Tassin et al. (1991), and Moore 
et al. (1987), in developing mouse and chick muscle (see also 
Roubin and Goridis,  1992). 
Although some of these studies, especially those in cul- 
ture, have been interpreted to indicate that the 145-ki) trans- 
membrane isoform is expressed in myoblasts whereas the 
130-kD lipid-linked form predominates in myotubes, our ob- 
servations are more compatible with the 145-kD isoform be- 
ing expressed in primary myotubes, and the 130-kD isoform 
being associated with secondary myoblasts and the myotubes 
they give rise to (see also Yoshimi et al., 1993). Consistent 
with this possibility, transfecting C2 myoblasts with lipid- 
linked NCAM enhanced fusion (Dickson et al., 1990),  and 
PLC extraction or immunological blocking of PI-linked pro- 
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1989). 
As reported by Yoshimi et al. (1993) we found the 155-kD 
isoform to be transiently expressed, being high between St 
32-38 and then being down regulated along with the 145-kD 
isoform later in development. The tightly and differentially 
regulated expression of all three isoforms during in vivo 
myogenesis suggests that they may be playing distinct roles. 
Histological localization of each of these isoforms at differ- 
ent stages of myogenesis at the light and electron microscopy 
level would be helpful in suggesting some of the potential 
roles they might be playing. 
Since no switch in expression of the 145- to the 130-kD 
form of NCAM  occurs  in  activity blocked muscles,  this 
regulation, due to alternative splicing, appears to be depen- 
dent on functional innervation. Secondary myogenesis does 
occur in dTC-treated muscles, but the normal exponential in- 
crease in secondary myotube formation is severely reduced 
(Fredette and Landmesser, 1991b). Therefore this reduction 
in the number of differentiating secondary myoblasts may be 
responsible for the decreased quantity of  lipid-linked NCAM 
observed in activity-blocked muscle. 
Polysialylation of  Particular NCAM Isoforms 
Of the major isoforms of NCAM expressed by developing 
muscle, only the  155-kD  transmembrane and the  130-kD 
lipid-linked molecules were polysialylated. Since our elec- 
tron microscopy analysis revealed that individual cells ex- 
press both non-polysialylated  and polysialylated  NCAM, the 
heterogeneity of polysialylation would have to be explained 
either by a sialytransferase differentially  recognizing specific 
isoforms or by a temporal regulation of the PSA biosynthetic 
pathway. In the latter case, the earliest NCAM isoforms syn- 
thesized (145 and a portion of the  155  kD) would escape 
polysialylation, whereas the isoforms that are synthesized 
later (the 130- and a portion of the 155-kD  form) would be 
polysialylated, as synthetic activity is increased. In develop- 
ing chicken brain,  Breen and Regan (Breen et al.,  1987; 
Breen and Regan,  1988)  have also observed that  140-kD 
NCAM is not polysialylated while other NCAM isoforms 
carry PSA.  This was also attributed to developmental up- 
regulation of PSA synthesis after expression of the 140-kD 
NCAM. Although the simplest explanation compatible with 
our data is a developmentally regulated biosynthetic pathway 
for PSA that can use all forms of NCAM, other possibilities 
can  not be  rigorously  excluded  until  metabolic  labeling 
studies are performed. In developing retina (Bartsch et al., 
1990) the 140-kD form of NCAM also escapes polysialyla- 
tion. However, in other systems, such as the developing spi- 
nal cord and sciatic nerve (Hoffman et al., 1982; Rutishauser 
et al., 1983, 1988; Finne et al., 1983; Tang et al., 1992) and 
in Wilms tumor cells (Zuber and Roth, 1990),  the 140-kD 
NCAM is polysialylated. Although little is known about the 
synthetic pathway for PSA in muscle, our study clearly indi- 
cates that PSA synthesis is regulated either directly or in- 
directly  by  nerve  activity,  since  the  usual  marked  up- 
regulation of PSA did not occur following activity blockade, 
even though some of the 130-kD  isoform was still synthe- 
sized. 
The pattern of PSA  regulation in muscle suggests that 
polysialylation is actively involved in the breaking of cell- 
cell bonds during myotube separation. This proposal is sup- 
ported by the fact that in other systems PSA appears to regu- 
late cell-cell interactions by acting as a physical impediment 
to molecular and/or membrane interactions (Acheson et al., 
1991;  Rutishauser et al.,  1988;  Landmesser et al.,  1988, 
1990; Tang et al., 1992; Zhang et al., 1992).  In the present 
case, while down regulation of N-cadherin could prevent fu- 
ture adhesion between myotubes, the introduction of large, 
bulky PSA groups into the intracellular space could promote 
the initial separation of the cells. The absence of polysialic 
acid on dTC-treated myotubes which fail to separate from 
clusters is consistent with this interpretation. Furthermore, 
myotube clusters increase in size between St 28 and 32, and 
then decrease to remain at a constant size through St 39, 
even though new myotubes continue to form within the clus- 
ters (unpublished observations). Some mechanism must there- 
fore exist to maintain the cluster size, and to prevent the 
clusters from becoming increasingly large, as occurs in the 
dTC-treated embryos. We have observed that virtually all of 
the 130-kD lipid-linked NCAM is polysialylated  at St 38 (af- 
ter which 130-kD NCAM but not PSA immunostaining per- 
sists) and that the expression of 130-kD NCAM and patches 
of PSA immunoreactivity can be observed at St 32. There- 
fore expression of polysialylated NCAM, along with a down 
regulation of N-cadherin,  may mediate the  separation of 
myotubes from clusters as they form and mature. 
Several groups have observed that PSA can be restricted 
to specific regions of NCAM-positive cells (Bartsch et al., 
1990;  Rougan et al.,  1993).  In cultured hippocampal neu- 
rons NCAM is expressed on both axons and dendrites but 
polysialic acid is restricted to axons and is concentrated near 
the peripheral regions of the axon and growth cone (Kim, 
W. T., W. E  Collins, and A. N. Van Den Pol,  1992,  Soc. 
Neurosci. Abst. 18:944). In Wilms tumor cells PSA is sparse 
or absent at cell-cell appositions where NCAM is present 
(Zuber and Roth, 1990). In our studies, we observed that vir- 
tually all of the 130-kD NCAM isoform contains PSA. It fol- 
lows, therefore, that this isoform must be restricted to the 
PSA-immunostained locations on cell surfaces. This raises 
the intriguing possibility that the 130-kD NCAM may be tar- 
geted to the free surfaces of developing muscle cells by vir- 
tue of the molecule's GPI anchor, which is known to serve 
as a targeting signal for glycoproteins in epithelial cells and 
in hippocampal neurons (Dotti et al.,  1991; Dotti and Si- 
mons, 1990;  Lisanti et al., 1988; Brown et al., 1989),  and 
also for lipid-linked NCAM transfected into epithelial cells 
(Powell et al., 1991). However, preliminary observations of 
the distribution of another GPI-linked molecule, T-cadherin, 
failed to show any such compartmentalization on developing 
myotubes (Fredette, B., unpublished observations). Since no 
PSA was observed at any stage on surfaces internal to the 
cluster, diffusion of the molecule to the outer surfaces of the 
cluster is unlikely. It is not possible to draw any conclusions 
about localization of the other NCAM isoforms, since they 
are either not polysialylated (145-kD NCAM) or only a por- 
tion is polysialylated (155-kD  NCAM). Thus, these forms 
may be distributed on any of  the NCAM-positive muscle sur- 
faces. 
After St 38,  polysialic acid immunostaining of muscle 
cells rapidly decreases whereas the 130-kD NCAM remains 
predominant. Therefore either PSA synthetic activity is rap- 
idly down regulated while 130-kD  NCAM continues to be 
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either to remove PSA from NCAM or to remove the entire 
polysialylated NCAM molecule from the myotube surface. 
In either case, the PSA present on the myotube surface at St 
38 must be replaced with non-polysialylated NCAM within 
24 h, which makes simple replacement by protein turnover 
unlikely.  Although no evidence for endogenous endoneur- 
aminidase has been reported in developing muscle, this pos- 
sibility remains to be explored further. Another possibility 
is that the GPI-linked, PSA-containing NCAM could be shed 
into the extracellular space. Indeed some of our EM observa- 
tions and others from Wilms tumor cells (Zuber and Roth, 
1990) where the PSA immunoreaction product appears as a 
thick fuzzy coat is at least suggestive of this possibility. In 
Aplysia sensory neurons, apCAM, another member of the Ig 
superfamily with some homology to NCAM, can be removed 
by  endocytotic  removal of the molecule from the  surface 
(Dailey  et al.,  1992).  As in their study,  we have  also ob- 
served coated vesicles that are NCAM immunopositive and 
which could be involved in removing NCAM from the cell 
surface. However, these were not PSA immunopositive. 
In summary, this study has provided a detailed description 
of N-cadherin and NCAM isoform expression in relation to 
the cell interactions which occur during primary and second- 
ary myogenesis.  We had previously observed that although 
both primary and secondary myogenesis occurs in the hind- 
limbs of dTC-treated  embryos, the quantity of both types of 
myotubes was drastically  reduced (Fredette and Landmesser, 
1991b).  The present study has shown that the expression of 
NCAM, PSA, and N-cadherin are also perturbed in muscles 
that develop in the absence of functional innervation,  lead- 
ing us to suggest that although both N-cadherin and NCAM 
adhesion are essential for the formation of myotubes (Knud- 
sen et al.,  1989,  1990a,b),  their continued expression and 
regulation is also essential to later stages of myogenesis. One 
of these later events,  namely separation  of myotubes from 
clusters, is clearly dependent on nerve activity.  Neuromus- 
cular blockade also perturbs CAM expression by abolishing 
PSA  expression,  by  preventing  an  NCAM  isoform switch 
that normally occurs after St 32, and by delaying the down 
regulation  of N-cadherin at myotube-myotube appositions. 
Whether or not these perturbations  in CAM expression are 
directly responsible  for preventing  the  separation  of myo- 
tubes from the clusters, and perhaps  ultimately in reducing 
the number of myotubes that are able to form in a muscle, 
remains to be directly tested. Although PSA has been:shown 
to attenuate  the cell-cell interactions  mediated by several 
cell adhesion molecules including NCAM,  it is not known 
if N-cadherin  function can be similarly affected. Experiments 
are currently in progress to enzymatically remove PSA from 
NCAM  and  to block N-cadherin  function with antibodies 
during  in  ovo  development.  In  preliminary  experiments, 
removal of PSA alone, by injection of endo-N, did not result 
in the greatly  enlarged clusters caused by activity blockade. 
Thus the normal down regulation of N-cadherin,  together 
with the upregulation  of PSA may both be required to allow 
myotubes to separate  from clusters.  In this case it may be 
necessary to interfere  with several  adhesion systems simul- 
taneously to mimic the effect of activity blockade. 
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